To evaluate efficacy and safety of Caralluma fimbriata in overweight and obese patients: A randomized, single blinded, placebo control trial

AIM: The aim of the following study is to evaluate the efficacy and safety of Caralluma fimbriata extract (CFE) in overweight and obese individuals in a prospective, randomized, placebo controlled trial. MATERIALS AND METHODS: Commercially available CFE was assessed in overweight and obese individua...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Perspect Clin Res
Päätekijät: Arora, Ekta, Khajuria, Vijay, Tandon, Vishal R., Sharma, Atul, Mahajan, Annil, Gillani, Zahid H., Choudhary, Naiyma
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Medknow Publications & Media Pvt Ltd 2015
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4314845/
https://ncbi.nlm.nih.gov/pubmed/25657901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-3485.148812
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia